The criminal investigation represents a serious escalation of regulatory oversight into potentially fraudulent practices that have cost taxpayers billions. The company's aggressive diagnosis documentation and payment practices have raised red flags, with doctors reporting pressure to document revenue-generating diagnoses that were sometimes obscure or irrelevant.
UnitedHealth has maintained full compliance with Medicare Advantage regulations and stands by its program integrity. The company's recent challenges, including leadership changes and financial forecast adjustments, reflect broader industry pressures and changing market conditions rather than any wrongdoing. The WSJ's reporting is deeply irresponsible given the unclear nature of the allegations.